I attended and overall I thought rather positive.
Some notes:
- Yacov was not present, he didn’t receive his visa in time and therefore wouldn’t of been able to make it.
- Steven Wood and Dr Brendan de Kauwe we’re present. Brendan was answering nearly all questions.
- probably the most annoying thing is because Brendan isn’t an executive director he wasn’t able to answer any operational queries.
- all MOU’s are still there. However, most (other than China) have been dependent on the other businesses part of our deal getting themselves sorted out. E.g the Singapore deal requires Singmore to get a fully functioning centre up and running so our products are actually relevant. (This was my take)
- it is expected the company will break even by year end simply from current monitoring services in America. Not including any product sales
- they are equally frustrated with slow CFDA. Company is apparently fully compliant and up to date with all FDA and CDFA requirements and submissions.
- Forums
- ASX - By Stock
- GMV
- Ann: Results of Meeting
Ann: Results of Meeting, page-12
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online